Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19

Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19

Summary: The coronavirus disease-19 (COVID-19) pandemic has ravaged global healthcare with previously unseen levels of morbidity and mortality. In this study, we performed large-scale integrative multi-omics analyses of serum obtained from COVID-19 patients with the goal of uncovering novel pathogen...

Full description

Bibliographic Details
Main Authors: Mustafa Buyukozkan, Sergio Alvarez-Mulett, Alexandra C. Racanelli, Frank Schmidt, Richa Batra, Katherine L. Hoffman, Hina Sarwath, Rudolf Engelke, Luis Gomez-Escobar, Will Simmons, Elisa Benedetti, Kelsey Chetnik, Guoan Zhang, Edward Schenck, Karsten Suhre, Justin J. Choi, Zhen Zhao, Sabrina Racine-Brzostek, He S. Yang, Mary E. Choi, Augustine M.K. Choi, Soo Jung Cho, Jan Krumsiek
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:iScience
Subjects:
Biological sciences
Clinical finding
Human metabolism
Medicine
Physiology
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004222008847

Internet

http://www.sciencedirect.com/science/article/pii/S2589004222008847

Similar Items